NFKB1 and metabolic dysfunction-associated steatotic liver disease: JPQGY can significantly alleviate the steatosis-inflammation-fibrosis of NAFLD mice, effectively prevent the downregulation of Pparα and AMPK, and upregulate Nf-κb, F4/80, SREGBP-1C, Cyp2e1 and LXRα.